These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32334607)

  • 1. Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports.
    Vroegindeweij LHP; Boon AJW; Wilson JHP; Langendonk JG
    Orphanet J Rare Dis; 2020 Apr; 15(1):105. PubMed ID: 32334607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia.
    Pelucchi S; Mariani R; Ravasi G; Pelloni I; Marano M; Tremolizzo L; Alessio M; Piperno A
    Parkinsonism Relat Disord; 2018 Jun; 51():36-42. PubMed ID: 29503155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment.
    Poli L; Alberici A; Buzzi P; Marchina E; Lanari A; Arosio C; Ciccone A; Semeraro F; Gasparotti R; Padovani A; Borroni B
    Neurol Sci; 2017 Feb; 38(2):357-360. PubMed ID: 27817091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron chelation therapy to prevent the manifestations of aceruloplasminemia.
    Bove F; Fasano A
    Neurology; 2015 Sep; 85(12):1085-6. PubMed ID: 26311749
    [No Abstract]   [Full Text] [Related]  

  • 5. Aceruloplasminemia presents as Type 1 diabetes in non-obese adults: a detailed case series.
    Vroegindeweij LH; van der Beek EH; Boon AJ; Hoogendoorn M; Kievit JA; Wilson JH; Langendonk JG
    Diabet Med; 2015 Aug; 32(8):993-1000. PubMed ID: 25661792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aceruloplasminemia, a rare condition not to be overlooked].
    Lobbes H; Reynaud Q; Mainbourg S; Lega JC; Durieu I; Durupt S
    Rev Med Interne; 2020 Nov; 41(11):769-775. PubMed ID: 32682623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deferasirox Might Be Effective for Microcytic Anemia and Neurological Symptoms Associated with Aceruloplasminemia: A Case Report and Review of the Literature.
    Miyake Z; Nakamagoe K; Yoshida K; Kondo T; Tamaoka A
    Intern Med; 2020 Jul; 59(14):1755-1761. PubMed ID: 32238721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights in the neurological phenotype of aceruloplasminemia in Caucasian patients.
    Vroegindeweij LHP; Langendonk JG; Langeveld M; Hoogendoorn M; Kievit AJA; Di Raimondo D; Wilson JHP; Boon AJW
    Parkinsonism Relat Disord; 2017 Mar; 36():33-40. PubMed ID: 28012953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aceruloplasminemia with Abnormal Compound Heterozygous Mutations Developed Neurological Dysfunction during Phlebotomy Therapy.
    Watanabe M; Ohyama K; Suzuki M; Nosaki Y; Hara T; Iwai K; Kono S; Miyajima H; Mokuno K
    Intern Med; 2018 Sep; 57(18):2713-2718. PubMed ID: 29709961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.
    Zanardi A; Conti A; Cremonesi M; D'Adamo P; Gilberti E; Apostoli P; Cannistraci CV; Piperno A; David S; Alessio M
    EMBO Mol Med; 2018 Jan; 10(1):91-106. PubMed ID: 29183916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.
    Vila Cuenca M; Marchi G; Barqué A; Esteban-Jurado C; Marchetto A; Giorgetti A; Chelban V; Houlden H; Wood NW; Piubelli C; Dorigatti Borges M; Martins de Albuquerque D; Yotsumoto Fertrin K; Jové-Buxeda E; Sanchez-Delgado J; Baena-Díez N; Burnyte B; Utkus A; Busti F; Kaubrys G; Suku E; Kowalczyk K; Karaszewski B; Porter JB; Pollard S; Eleftheriou P; Bignell P; Girelli D; Sanchez M
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing aceruloplasminemia: navigating through red herrings.
    Kharel Z; Kharel H; Phatak PD
    Ann Hematol; 2024 Jun; 103(6):2173-2176. PubMed ID: 38637332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aceruloplasminemia: Waiting for an Efficient Therapy.
    Piperno A; Alessio M
    Front Neurosci; 2018; 12():903. PubMed ID: 30568573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of heterozygosis for aceruloplasminemia.
    Borges MD; de Albuquerque DM; Lanaro C; Costa FF; Fertrin KY
    Am J Med Genet B Neuropsychiatr Genet; 2019 Jun; 180(4):266-271. PubMed ID: 30901137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging for the quantitative assessment of brain iron in aceruloplasminemia: A postmortem validation study.
    Vroegindeweij LHP; Wielopolski PA; Boon AJW; Wilson JHP; Verdijk RM; Zheng S; Bonnet S; Bossoni L; van der Weerd L; Hernandez-Tamames JA; Langendonk JG
    Neuroimage; 2021 Dec; 245():118752. PubMed ID: 34823024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aceruloplasminaemia: a rare but important cause of iron overload.
    Doyle A; Rusli F; Bhathal P
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25976187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aceruloplasminemia: an update.
    Kono S
    Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of desferrioxamine in the treatment of aceruloplasminemia.
    Miyajima H; Takahashi Y; Kamata T; Shimizu H; Sakai N; Gitlin JD
    Ann Neurol; 1997 Mar; 41(3):404-7. PubMed ID: 9066364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of oral iron chelator treatment with deferasirox in an aceruloplasminemia patient with a novel ceruloplasmin gene mutation.
    Suzuki Y; Yoshida K; Aburakawa Y; Kuroda K; Kimura T; Terada T; Kono S; Miyajima H; Yahara O
    Intern Med; 2013; 52(13):1527-30. PubMed ID: 23812204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aceruloplasminemia With Psychomotor Excitement and Neurological Sign Was Improved by Minocycline (Case Report).
    Hayashida M; Hashioka S; Miki H; Nagahama M; Wake R; Miyaoka T; Horiguchi J
    Medicine (Baltimore); 2016 May; 95(19):e3594. PubMed ID: 27175663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.